Terms: = Head and neck cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
18 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.
Rajasekaran N; Wang X; Ravindranathan S; Chin DJ; Tseng SY; Klakamp SL; Widmann K; Kapoor VN; Vexler V; Keegan P; Yao S; LaVallee T; Khare SD
Cancer Immunol Immunother; 2024 Feb; 73(3):60. PubMed ID: 38400933
[TBL] [Abstract] [Full Text] [Related]
3. Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway.
Luo X; Qiu Y; Fitzsimonds ZR; Wang Q; Chen Q; Lei YL
Oncogene; 2024 Feb; 43(6):388-394. PubMed ID: 38177410
[TBL] [Abstract] [Full Text] [Related]
4. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
Janczewski LM; Shah D; Wells A; Bentrem DJ; Abad JD; Chawla A
J Surg Oncol; 2023 Jun; 127(7):1116-1124. PubMed ID: 36905333
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacologic Inhibition of shp2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1.
Kurupi R; Floros KV; Jacob S; Chawla AT; Cai J; Hu B; Puchalapalli M; Coon CM; Khatri R; Crowther GS; Egan RK; Murchie E; Greninger P; Dalton KM; Ghotra MS; Boikos SA; Koblinski JE; Harada H; Sun Y; Morgan IM; Basu D; Dozmorov MG; Benes CH; Faber AC
Cancer Res Commun; 2022 Sep; 2(9):1061-1074. PubMed ID: 36506869
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics analysis identifies potential biomarkers involved in the metastasis of locoregionally advanced nasopharyngeal carcinoma.
Hu R; Xu X; Mo L; Chen M; Liu Y
Medicine (Baltimore); 2022 Sep; 101(35):e30126. PubMed ID: 36107539
[TBL] [Abstract] [Full Text] [Related]
7. Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
Oba T; Chino T; Soma A; Shimizu T; Ono M; Ito T; Kanai T; Maeno K; Ito KI
Endocr J; 2020 Dec; 67(12):1215-1226. PubMed ID: 32814730
[TBL] [Abstract] [Full Text] [Related]
8. ptpn11 Knockdown Prevents Changes in the Expression of Genes Controlling Cell Cycle, Chemotherapy Resistance, and Oncogene-Induced Senescence in Human Thyroid Cells Overexpressing BRAF V600E Oncogenic Protein.
Putlyaeva LV; Demin DE; Uvarova AN; Zinevich LS; Prokofjeva MM; Gazizova GR; Shagimardanova EI; Schwartz AM
Biochemistry (Mosc); 2020 Jan; 85(1):108-118. PubMed ID: 32079522
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and prognostic significance of shp2 and Hook1 expression in patients with thyroid carcinoma.
Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
[TBL] [Abstract] [Full Text] [Related]
10. ns1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase shp2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract] [Full Text] [Related]
12. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract] [Full Text] [Related]
13. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
Peng G; Cao RB; Li YH; Zou ZW; Huang J; Ding Q
Mol Med Rep; 2014 Oct; 10(4):1709-16. PubMed ID: 25109634
[TBL] [Abstract] [Full Text] [Related]
14. shp2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
[TBL] [Abstract] [Full Text] [Related]
15. Expressions of Src homology 2 domain-containing phosphatase and its clinical significance in laryngeal carcinoma.
Dong LB; Li GQ; Tian ZH; Wang ZM; Xu K
Genet Mol Res; 2013 Oct; 12(4):4207-12. PubMed ID: 24114215
[TBL] [Abstract] [Full Text] [Related]
16. Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus.
Moralès O; Richard A; Martin N; Mrizak D; Sénéchal M; Miroux C; Pancré V; Rommelaere J; Caillet-Fauquet P; de Launoit Y; Delhem N
PLoS One; 2012; 7(2):e32197. PubMed ID: 22359669
[TBL] [Abstract] [Full Text] [Related]
17. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract] [Full Text] [Related]
18. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
[TBL] [Abstract] [Full Text] [Related]
